Akèy › Defisyans Vizyèl ak Sebre
Etid klinik pou Defisyans Vizyèl ak Sebre ap rekrite nan Etazini
15 etid pou Defisyans Vizyèl ak Sebre ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
- Florid4 etid
- Illinois3 etid
- Kalifòni4 etid
- Massachusetts5 etid
- Michigan3 etid
- New York3 etid
- Pennsylvania3 etid
- Texas3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Virtual Reality Aniseikonia and Metamorphopsia Testing
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07838181OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07140783Mechanisms of Visual Restoration After Occipital Stroke
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 a 80 · Tout sèks · Mizajou Aug 26, 2026 · NCT07134777Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05844982Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Ap rekriteFaz 3
Laj 18 a 50 · Tout sèks · Mizajou Aug 14, 2026 · NCT07623668Providing Access to the Visual Environment
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 3 a 21 · Tout sèks · Mizajou Jul 31, 2026 · NCT00341744Valproate for the Treatment of Residual Amblyopia
Ap rekriteFaz 1/2
Laj 8 a 17 · Tout sèks · Mizajou Jul 30, 2026 · NCT07226141Stem Cell Ophthalmology Treatment Study II
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT03011541Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Ap rekriteFaz 3
Laj 6 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT06891443Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Mar 11, 2026 · NCT02521311Improving Visual Field Deficits With Noninvasive Brain Stimulation
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Mar 4, 2026 · NCT05085210Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06934577Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision
Ap rekrite
Laj 12 a 99 · Tout sèks · Mizajou Dec 11, 2025 · NCT05028712Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates
Ap rekriteEtid obsèvasyon
31 Weeks – 42 Weeks · Tout sèks · Mizajou Dec 10, 2025 · NCT07275021Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2025 · NCT07073521Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.